Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study

Published 2008 View Full Article

Authors

Keywords

Journal

ATHEROSCLEROSIS

Volume 205, Issue 1, Pages 227-232

Publisher

Elsevier BV

Online

2008-12-10

DOI

10.1016/j.atherosclerosis.2008.11.032

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

ATHEROSCLEROSIS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Ask a Question. Answer a Question.